Lectures (Video)
- 1. What Is Biomedical Engineering?
- 2. What Is Biomedical Engineering? (cont.)
- 3. Genetic Engineering
- 4. Genetic Engineering (cont.)
- 5. Cell Culture Engineering
- 6. Cell Culture Engineering (cont.)
- 7. Cell Communication and Immunology
- 8. Cell Communication and Immunology (cont.)
- 9. Biomolecular Engineering: Engineering of Immunity
- 10. Biomolecular Engineering: Engineering of Immunity (cont.)
- 11. Biomolecular Engineering: General Concepts
- 12. Biomolecular Engineering: General Concepts (cont.)
- 13. Cardiovascular Physiology
- 14. Cardiovascular Physiology (cont.)
- 15. Cardiovascular Physiology (cont.)
- 16. Renal Physiology
- 17. Renal Physiology (cont.)
- 18. Biomechanics and Orthopedics
- 19. Biomechanics and Orthopedics (cont.)
- 20. Bioimaging
- 21. Bioimaging (cont.)
- 22. Tissue Engineering
- 23. Tissue Engineering (cont.)
- 24. Biomedical Engineers and Cancer
- 25. Biomedical Engineers and Artificial Organs
Frontiers of Biomedical Engineering - Lecture 24
|
Get the Flash Player to view video.
Lecture 24 - Biomedical Engineers and Cancer
Professor Saltzman uses cancer diagnosis and treatment as an example to demonstrate the some applications of biomedical engineering technologies and methods. Some issues involved in cancer treatment, such as tumor angiogenesis, radiation sensitivity, drug localization, and cancer stem cells are mentioned. Next, he describes the phases (I-IV), in compliance to guidelines enforced by the Food and Drug Administration (FDA), which a new drug compound must go through to gain approval prior to public distribution/sale. Finally, Professor Saltzman draws attention to the areas that biomedical engineers may contribute to, to improve this process.
Prof. W. Mark Saltzman
BENG 100 Frontiers of Biomedical Engineering, Spring 2008 (Yale University: Open Yale) http://oyc.yale.edu Date accessed: 2009-01-06 License: Creative Commons BY-NC-SA |
